Header Image

11th. INTERAMERICAN ONCOLOGY CONFERENCE

HYBRID CONFERENCE
JULY 17 -18 , 2025

CONFERENCE  CO-CHAIRS
Alex Adjei, Cleveland, USA
Enriqueta Felip, Barcelona, Spain
Natasha B. Leighl, Toronto, Canada
Christian Rolfo, Ohio, USA

SCIENTIFIC COMMITTEE
Alex Adjei, MD, Ph.D, Cleveland Clinic, Cleveland, USA
Joaquim Bellmunt, MD, PhD, Harvard, Boston, USA
Enriqueta Felip, MD, Ph.D, VHIO, Barcelona, Spain
Natasha Leighl, MD, MMSC, FRCPC, FASCO, P. Margaret CC, Toronto, Canada
Ana Oaknin, MD, Ph.D, VHIO, Barcelona, Spain
Antoni Ribas, MD, Ph.D, UCLA, Los Angeles, USA
Christian Rolfo, MD, PhD, MBA, Dr.h.c, A.G. James Cancer Hospital, Ohio, USA

FACULTY

Alex A. Adjei, MD, PH.D, FACP
Cleveland Clinic , USA
Chairman Taussig Cancer Institute - Cleveland Clinic - Cleveland, Ohio, USA

View profile

Stephen M. Ansell, MD, Ph.D
Mayo Clinic Cancer Center, USA
CHAIR LYMPHOMA GROUP - MAYO CLINIC- ROCHESTER, MINNESOTA, USA

View profile

Carlos H. Barrios, MD
Hospital São Lucas, PUCRS , Brazil
Grupo Oncoclínicas de Pesquisa em Oncologia, Hospital São Lucas, PUCRS - Latin American Cooperative Oncology Group (LACOG) - Porto Alegre RS, Brazil

View profile

Joaquim Bellmunt, MD, Ph.D
Dana-Farber Cancer Institute , USA
Associate Professor, Medicine - Harvard Medical School - Director Bladder Cancer Center - Dana-Farber Cancer Institute - Boston, Massachusetts, USA

View profile

Enriqueta Felip, MD, Ph.D
Vall d’Hebron Institute of Oncology , Spain
Section in Chief, Medical Oncology Department - Vall d’Hebron University Hospital - Head, Thoracic Oncology and H&N Cancer Unit - Vall d’Hebron Institute of Oncology (VHIO) - Professor of Medicine, UVic-UCC - Vall d’Hebron Institute of Oncology - Barcelona, Spain

View profile

GUILLERMO GARCIA-MANERO, MD
MD Anderson Cancer Center, USA
CHIEF, SECTION OF MDS- MD ANDERSON CANCER CENTER- HOUSTON, TEXAS, USA.

View profile

IRENE GHOBRIAL, MD
DANA-FARBER CANCER INSTITUTE, USA
SENIOR VICE PRESIDENT FOR EXPERIMENTAL MEDICINE- DANA-FARBER CANCER INSTITUTE- BOSTON, USA

View profile

NATASHA LEIGHL, MD, MMSC, FRCPC, FASCO
PRINCESS MARGARET CANCER CENTRE, CANADA.
OSI PHARMACEUTICALS FOUNDATION CHAIR - PRINCESS MARGARET CANCER CENTRE- TORONTO, CANADA

View profile

CLARA MONTAGUT, MD, PH.D
HOSPITAL DEL MAR RESEARCH INSTITUTE, SPAIN
HEAD, GASTROINTESTINAL CANCER UNIT- HOSPITAL DEL MAR RESEARCH INSTITUTE-BARCELONA, SPAIN

View profile

Ana Oaknin, MD, PH.D
Vall d´Hebron Institute of Oncology, Spain
Head of Gynecological Cancer Program - Medical Oncology Department - Vall d´Hebron University Hospital - Vall d´Hebron Institute of Oncology( VHIO) - Barcelona, Spain

View profile

BEGOÑA PEREZ VALDERRAMA, MD
UNIVERSITY HOSPITAL VIRGEN DEL ROCÍO, SPAIN
GENITOURINARY AND GYNECOLOGICAL TUMORS UNIT- UNIVERSITY HOSPITAL VIRGEN DEL ROCÍO- SEVILLE, SPAIN

View profile

Antoni Ribas, MD, Ph.D
Jonsson Comprehensive Cancer Center , USA
Professor of Medicine and Surgery - Professor of Molecular and Medical Pharmacology - Director Tumor Immunology Program, Jonsson - Comprehensive Cancer Center (JCCC) - David Geffen School of Medicine, UCLA - Los Angeles, California, USA

View profile

Christian Rolfo, MD, PH.D, MBA, Dr.hc
ARTHUR G. JAMES CANCER HOSPITAL, Ohio, USA
DIRECTOR, DIVISION OF MEDICAL ONCOLOGY- ASSOCIATE DIRECTOR FOR EARLY PHASE CLINICAL TRIALS - A.G. JAMES CANCER HOSPITAL AND SOLOVE RESEARCH INSTITUTE- OHIO, USA

View profile

HARRY YOON, MD, MHS
MAYO CLINIC COMPREHENSIVE CANCER CENTER, USA
ENTERPRISE VICE-CHAIR, GASTROINTESTINAL CANCER DISEASE GROUP- MAYO CLINIC COMPREHENSIVE CANCER CENTER - ROCHESTER, MINNESOTA, USA

View profile